For the past one and a half centuries, we have lived in an era of technological progress and high technology. An era in which scientific discoveries occur almost daily and continuously change the world for the better. But how do we determine whether a particular invention is safe? How can we know that a newly invented machine will not break down during operation? How can we know whether a newly developed material will withstand the effects of certain substances?
Testing provides answers to all questions regarding efficacy and safety. This is particularly important for pharmaceutical drugs, as it is impossible to fully predict the absorption and impact of the active substance on the human body; therefore, only laboratory research and phased clinical trials can enable the creation of the most effective drug, whose efficacy and safety will be irrefutably proven, anticipate all risks and side effects, and compile instructions for use. And it is precisely this that Yevheniia Rudkovska does, who delivered a guest lecture to bachelor’s and master’s degree students at BTEC on March 28.
The lecturer’s professional career began at our esteemed National University of Food Technologies, whose diploma is, as is well known, recognized throughout the world. It is thanks to this that Yevheniia was able to continue her education in Estonia, where she worked in the biotechnology company ARTeSYN Biosolutions, and is currently a successful specialist at Viedoc in Sweden (headquarters in the city of Uppsala). Initially, the international company Viedoc was founded in 2003 for the purpose of organizing clinical trials, and from 2012 to the present day, it is a company developing software for clinical trials and has its offices throughout the world: from the United States to Japan.
Ms. Yevheniia focused the audience’s attention on the peculiarities of conducting clinical trials and their phases, spoke about modern electronic systems for recording results, and introduced the innovative products of Viedoc (the “core” consists of Viedoc Clinic, Viedoc Admin, and Viedoc Designer, and there are also a large number of cutting-edge auxiliary programs).
It should be noted that clinical trials are conducted on subjects (patients) in order to assess the degree of impact of a pharmaceutical drug or medical device (for example, implants, pacemakers) or a certain molecule on human health, assess safety and efficacy, find a new way to treat a disease, or compare it with already existing compounds with similar properties. Moreover, clinical trials make it possible to detect certain disorders in the organisms of subjects at early stages or improve the quality of life of people already diagnosed with diseases.
Thus, beginning in 2003, the company Viedoc and its employees stand as guardians of the safety and efficacy of pharmaceutical drugs, applying modern technologies in their work, including the most advanced software. And as long as clinical trials are conducted by such qualified specialists using the latest technologies, one need not worry about the quality of pharmaceutical products, as they have passed all stages of rigorous verification. And verifiability means reliability.
It is worth noting that at the end of the guest lecture, all those who wished had the opportunity to ask Ms. Yevheniia questions and receive thorough answers, and even more: practical advice on successfully passing an interview for future employment! We express sincere words of gratitude to Yevheniia Rudkovska for the lecture delivered and the opportunity to learn valuable and useful information!
Volodymyr Verbiy, Kateryna Hvozdets’ka, BT-3-1









